Earnings Preview For Akebia Therapeutics
Portfolio Pulse from Benzinga Insights
Akebia Therapeutics (NASDAQ:AKBA) is scheduled to release its quarterly earnings report on March 14, 2024, with an expected EPS of $-0.04. Investors are hopeful for a beat on this estimate and positive guidance for the next quarter. Historical data shows a correlation between earnings performance and stock price movement. Shares have risen 105.59% over the last 52 weeks, indicating a bullish sentiment among long-term shareholders.

March 13, 2024 | 2:05 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Akebia Therapeutics is expected to report an EPS of $-0.04 for the upcoming quarter. Historical performance and stock price reaction to earnings announcements suggest a potential impact on the stock price following the report.
Given the historical sensitivity of AKBA's stock price to earnings performance, the upcoming report could influence short-term stock movement. However, the score is neutral (0) due to the uncertainty surrounding the actual results and their alignment with market expectations.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100